Mesenchymal stem cells (MSCs), as self-renewing multipotent stromal cells, have been
considered promising agents for cancer treatment. A large number of studies have …

The discovery of the interesting intrinsic properties of graphene, a two‐dimensional
nanomaterial, has boosted further research and development for various types of …

Glioblastoma is the most aggressive malignant primary brain tumor, with a dismal prognosis
and a devastating overall survival. Despite aggressive surgical resection and adjuvant …

Progress in genetic engineering led to the emergence of some viruses as potent anticancer
therapeutics. These oncolytic viruses combine self-amplification with dual antitumor action …

Abstract Background and Objective Increasing interest has developed in the therapeutic
potential of bone marrow-derived mesenchymal stem cells (MSCs) for the treatment of …

The role of mesenchymal stem cells (MSCs) in the breast tumor microenvironment (TME) is
significant and multifaceted. MSCs are recruited to breast tumor sites through molecular …

Mesenchymal stem/progenitor cells (MSCs) are key players in regenerative medicine,
relying principally on their differentiation/regeneration potential, immunomodulatory …

Combined gene and cell therapy are promising strategies for cancer treatment. Given the
complexity of cancer, several approaches are actively studied to fight this disease. Using …

Cell-based gene therapy holds a great promise for the treatment of human malignancy.
Among different cells, mesenchymal stem cells (MSCs) are emerging as valuable anti …

Oncolytic viruses can target neoplasms, triggering oncolytic and immune effects. Their
delivery to melanoma lesions remains challenging. Bone-marrow-derived mesenchymal …